Biogen Tells High Court Interference Appeals Are Not Limited To Federal Circuit
WASHINGTON, D.C. — The Leahy-Smith America Invents Act (AIA) allows district court review of patent interferences before Sept. 16, 2012, Biogen MA Inc. argues to the U.S. Supreme Court in a...To view the full article, register now.
Already a subscriber? Click here to view full article